Investigational drug · Phase 3
Cytisinicline
Also called: Cytisine
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Vaping Cessation, Smoking Cessation.
Phase 3Last checked: Nov 20, 2026Latest source record: Feb 6, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
2
1 still active
All registered trials
31
Any phase or sponsor naming "Cytisinicline"
First trial start
2024
May 28, 2024
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "Cytisinicline", any sponsor or status.
Conditions studied
As listed on its trial records.
- Vaping Cessation
- Smoking Cessation
Approved drugs for the same conditions: Smoking cessation
Largest trials
Live from ClinicalTrials.gov: studies naming "Cytisinicline" as an intervention, largest first.
- Screening and Multiple Intervention on Lung EpidemicsPivotal-lookingActive, not recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoAcademic, hospital or other
NCT03654105 · 2,000 participants (planned) · Start Jul 23, 2019 · Primary completion Dec 31, 2024
Drug: Cytisine; Acetylsalicylic acid · For: Inflammation; Smoking Cessation; Diet Modification and 2 more
Sites: Milan, Italy
- PeRiopEratiVE SmokiNg CessaTion TrialPivotal-lookingActive, not recruiting
Population Health Research InstituteAcademic, hospital or other
NCT05102123 · 1,720 participants (planned) · Start Jan 15, 2024 · Primary completion Jul 1, 2026
Drug: Cytisine · For: Smoking (Tobacco) Addiction; Smoking Cessation
Sites: Hamilton, Canada; Kingston, Canada; London, Canada · 4 sites in all
- Comparative Effectiveness of Cystine Versus Nicotine Replacement TherapyPivotal-lookingCompleted
Loma Linda UniversityAcademic, hospital or other
NCT04126135 · 1,307 participants · Start Jan 27, 2022 · Primary completion Mar 4, 2024
Drug: Cytisine; Nicotine Replacement Therapy (NRT) · For: Nicotine Addiction
Sites: Ulaanbaatar, Mongolia
- A Study of Cytisinicline for Smoking Cessation in Adult SmokersPivotal-lookingCompleted
Achieve Life SciencesIndustry
NCT04576949 · 810 participants · Start Oct 13, 2020 · Primary completion Dec 23, 2021
Drug: Cytisinicline; Placebo · For: Smoking Cessation
Sites: Mobile, Alabama; Phoenix, Arizona; Coral Gables, Florida · 17 sites in all
- Cytisine and E-cigarettes With Supportive Text-messaging for Smoking Cessation (Cess@Tion)Pivotal-lookingCompleted
University of Auckland, New ZealandAcademic, hospital or other
NCT05311085 · 807 participants · Start May 5, 2022 · Primary completion May 2, 2024
Drug: Cytisine; Nicotine delivered via an e-cigarette · For: Smoking Cessation
Sites: Auckland, New Zealand
- Phase 3 Trial Evaluating the Efficacy and Safety of Cytisinicline for Vaping Cessation in Adults Using Nicotine-Containing E CigarettesPivotal-lookingNot yet recruiting
Achieve Life SciencesIndustry
NCT07392125 · 800 participants (planned) · Start May 15, 2026 · Primary completion Nov 15, 2026
Drug: Cytisinicline; Placebo · For: Vaping Cessation
- A Second Study of Cytisinicline for Smoking Cessation in Adult SmokersPivotal-lookingCompleted
Achieve Life SciencesIndustry
NCT05206370 · 792 participants · Start Jan 20, 2022 · Primary completion Mar 21, 2023
Drug: Cytisinicline; Placebo · For: Smoking Cessation
Sites: DeLand, Florida; Fort Myers, Florida; Jacksonville, Florida · 12 sites in all
- Cytisine Versus Varenicline for Smoking CessationPivotal-lookingCompleted
University of Auckland, New ZealandAcademic, hospital or other
NCT02957786 · 679 participants · Start Sep 18, 2017 · Primary completion Oct 10, 2019
Drug: Cytisine; Varenicline · For: Smoking Cessation
Sites: Auckland, New Zealand
- Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette SmokersPivotal-lookingCompleted
Achieve Life SciencesIndustry
NCT06435221 · 479 participants · Start May 28, 2024 · Primary completion Sep 29, 2025
Drug: Cytisinicline · For: Smoking Cessation; Vaping Cessation
Sites: Mobile, Alabama; Tempe, Arizona; Little Rock, Arkansas · 29 sites in all
- Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV)Pivotal-lookingCompleted
Boston Medical CenterAcademic, hospital or other
NCT02797587 · 400 participants · Start Jul 19, 2017 · Primary completion Apr 30, 2020
Drug: Varenicline; Cytisine and 4 more · For: HIV Infection; Alcohol Use; Smoking
Sites: Saint Petersburg, Russia
Newest research
PubMed records naming it or its code names, newest first.
- Future Treatments for Tobacco Dependence.
Jimenez-Ruiz CA, Cristóbal Fernández MI, de Granda-Orive JI, et al. · Open Respir Arch 2027
- Awareness, use and future interest in cytisine for smoking cessation in adults who smoke or have quit within the past year in the UK: A mixed-methods study.
Devereux M, Lyu J, Buss VH, et al. · Addict Behav Rep 2026
- Nurse-led smoking cessation with cytisinicline in primary care: An intervention study.
Majo García R, Espinosa Villoria MG, Fernández-Martínez MN, et al. · Int J Nurs Stud Adv 2026
- High-throughput screening of natural products identifies candidate photoprotective compounds for a prototype broad-spectrum sunscreen formulation.
Zhou AG, Kwak A, Yu B, et al. · Photochem Photobiol 2026
- Cytisine for Smoking Cessation: A Narrative Review of an Underutilized Therapy.
Diana C, di Grazia A, Verruso B, et al. · Pulm Ther 2026
- Association between early treatment response and long-term smoking cessation: A real-world retrospective cohort study of cytisine treatment.
Arslan Y, Şahin BÖ, Aygül A, et al. · Tob Induc Dis 2026
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.